Mineralys Therapeutics
39 open jobs
Manager, Commercial Accounting
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Manager, Commercial Accounting at Mineralys Therapeutics seen live 2 days ago posted 5 days agoSenior Director, Analytical Sciences
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Senior Director, Analytical Sciences at Mineralys Therapeutics seen live 2 days ago posted 6 days agoSenior Director, Commercial Manufacturing
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Senior Director, Commercial Manufacturing at Mineralys Therapeutics seen live 2 days ago posted 6 days agoDirector, Market Research & Competitive Intelligence
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Director, Market Research & Competitive Intelligence at Mineralys Therapeutics seen live 2 days ago posted 9 days agoSr. Manager, Compliance Operations
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Sr. Manager, Compliance Operations at Mineralys Therapeutics seen live 2 days ago posted 14 days agoContracts Manager
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Regional Sales Director - New Orleans
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Regional Sales Director - New Orleans at Mineralys Therapeutics seen live 2 days ago posted 17 days agoSenior Vice President, Regulatory Affairs
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Senior Vice President, Regulatory Affairs at Mineralys Therapeutics seen live 2 days ago posted 25 days agoDirector Biostatistics
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Territory Manager - Tallahassee, FL
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Tallahassee, FL at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Poughkeepsie, NY
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Poughkeepsie, NY at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - N. Cincinnati, OH
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - N. Cincinnati, OH at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Martinsville, VA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Martinsville, VA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Humble, TX
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Humble, TX at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Hagerstown, MD
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Hagerstown, MD at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Gilbert, AZ
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Gilbert, AZ at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Edmond, OK
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Edmond, OK at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Boston, MA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Boston, MA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Washington, D.C.
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Washington, D.C. at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Salem, OR
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Salem, OR at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Pittsburgh, PA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Pittsburgh, PA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Newport News, VA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Newport News, VA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Newport Beach, CA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Newport Beach, CA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - New York, NY
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - New York, NY at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Meridian, ID
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Meridian, ID at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Laguna Hills, CA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Laguna Hills, CA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Joliet, IL
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Joliet, IL at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Jamaica, NY
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Jamaica, NY at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Florissant, MO
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Florissant, MO at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Covington, LA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Covington, LA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Columbus, OH
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Columbus, OH at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Augusta, GA
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Augusta, GA at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Annapolis, MD
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Annapolis, MD at Mineralys Therapeutics seen live 2 days ago posted 88 days agoTerritory Manager - Yonkers, NY
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Territory Manager - Yonkers, NY at Mineralys Therapeutics seen live 2 days ago posted 88 days agoDirector, Compliance
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Associate Director, Health Economics & Outcomes Research/Real-World Evidence (HEOR/RWE)
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Associate Director, Health Economics & Outcomes Research/Real-World Evidence (HEOR/RWE) at Mineralys Therapeutics seen live 2 days ago posted 118 days agoDirector, HCP Marketing
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Executive Director, Clinical Development
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Executive Director, Clinical Development at Mineralys Therapeutics seen live 2 days ago posted 168 days agoSr. Director, HCP Marketing
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its
Applyto Sr. Director, HCP Marketing at Mineralys Therapeutics seen live 2 days ago posted 221 days ago